Teva Pharmaceuticals USA, Inc. recalls Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-41
Recalled April 17, 2013 · FDA recall D-247-2013 · Teva Pharmaceuticals USA
Hazard
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles. · FDA Class II
Units
62,187 bottles
Sold at
Nationwide
Description
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
Product
Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.
Manufacturer(s)
Teva Pharmaceuticals USA, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →